TYR Tyratech (DI/S)

TIDMTYR TIDMTYRU

RNS Number : 3763E

TyraTech, Inc.

08 April 2014

8 April 2014

TyraTech, Inc.

("TyraTech" or the "Company")

Director's Dealings

TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that, it was notified today that, on 7 April 2014, Mr Alan Reade and his wife, Mrs Alyson Reade, sold 202,500 Common shares of US$0.001 per share (AIM: TYR) ("TyraTech shares"); at a price of 11.80 pence per TyraTech share.

Mr & Mrs Reade then immediately repurchased 197,500 Common shares at 11.82 pence per TyraTech share; these shares being acquired equally into their respective ISA accounts.

Following these transactions, Alan Reade's beneficial interest in the Company has reduced by 5,000 TyraTech shares to 12,481,358 TyraTech shares representing approximately 6.09% of the Company's issued share capital.

For further information please contact:

 
TyraTech Inc. 
 Alan Reade, Non-Executive Chairman                    Tel: +44 7841978709 
 Bruno Jactel, Chief Executive Officer                Tel: +1 919 415 4340 
SPARK Advisory Partners Limited, Nominated Adviser 
 Matt Davis / Mark Brady                              Tel: +44203 368 3552 
                                                      Tel: +44203 368 3551 
Allenby Capital Limited , Joint Broker 
 Chris Crawford                                      Tel: +44 20 3328 5656 
Whitman Howard Limited, Joint Broker 
 Ranald McGregor-Smith / Niall Devins                Tel: +44 20 7087 4555 
Walbrook, Financial PR and IR 
 Bob Huxford /Guy McDougall (Public Relations)       Tel: +44 20 7933 8792 
 Paul Cornelius (Investor Relations)                 Tel: +44 20 7933 8794 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSSSMFWAFLSESL

Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024

Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024